Search research articles
Contact Us
Filters
Showing results (161-170 of 188) with videos related to
Page
of 19
Sort By:
NPJ Parkinson'S Disease
|
March 22, 2022
Transcriptional analysis of peripheral memory T cells reveals Parkinson's disease-specific gene signatures
Rekha Dhanwani, João Rodrigues Lima-Junior, Ashu Sethi, et al.
Nature Communications
|
April 22, 2020
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease
Cecilia S Lindestam Arlehamn, Rekha Dhanwani, John Pham, et al.
Journal of the Neurological Sciences
|
December 10, 2022
Unaltered T cell responses to common antigens in individuals with Parkinson's disease
Gregory P Williams, Kaylin Muskat, April Frazier, et al.
Journal of Parkinson'S Disease
|
June 11, 2023
Levodopa Carbidopa Intestinal Gel in Advanced Parkinson's Disease: DUOGLOBE Final 3-Year Results
K Ray Chaudhuri, Norbert Kovács, Francesco E Pontieri, et al.
Molecular Neurodegeneration
|
January 11, 2022
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain
Enquan Xu, Ravindra Boddu, Hisham A Abdelmotilib, et al.
Neurology and Therapy
|
October 4, 2025
Improvement in Motor Consistency and Stability with Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Post Hoc Analysis of Two Phase 3 Clinical Trials
Rajesh Pahwa, Jason Aldred, Michael J Soileau, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 25, 2017
Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials
Alberto J Espay, Michael A Schwarzschild, Caroline M Tanner, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 16, 2019
Widespread Tau-Specific CD4 T Cell Reactivity in the General Population
Cecilia S Lindestam Arlehamn, John Pham, Roy N Alcalay, et al.
Neurodegenerative Disease Management
|
September 3, 2020
Application of the '5-2-1' screening criteria in advanced Parkinson's disease: interim analysis of DUOGLOBE
Jason Aldred, Marieta Anca-Herschkovitsch, Angelo Antonini, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2007
Molecular markers of early Parkinson's disease based on gene expression in blood
Clemens R Scherzer, Aron C Eklund, Lee J Morse, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 188) with videos related to
Sort By:
Page
of 19
NPJ Parkinson'S Disease
|
March 22, 2022
Transcriptional analysis of peripheral memory T cells reveals Parkinson's disease-specific gene signatures
Rekha Dhanwani, João Rodrigues Lima-Junior, Ashu Sethi, et al.
Nature Communications
|
April 22, 2020
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease
Cecilia S Lindestam Arlehamn, Rekha Dhanwani, John Pham, et al.
Journal of the Neurological Sciences
|
December 10, 2022
Unaltered T cell responses to common antigens in individuals with Parkinson's disease
Gregory P Williams, Kaylin Muskat, April Frazier, et al.
Journal of Parkinson'S Disease
|
June 11, 2023
Levodopa Carbidopa Intestinal Gel in Advanced Parkinson's Disease: DUOGLOBE Final 3-Year Results
K Ray Chaudhuri, Norbert Kovács, Francesco E Pontieri, et al.
Molecular Neurodegeneration
|
January 11, 2022
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain
Enquan Xu, Ravindra Boddu, Hisham A Abdelmotilib, et al.
Neurology and Therapy
|
October 4, 2025
Improvement in Motor Consistency and Stability with Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Post Hoc Analysis of Two Phase 3 Clinical Trials
Rajesh Pahwa, Jason Aldred, Michael J Soileau, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 25, 2017
Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials
Alberto J Espay, Michael A Schwarzschild, Caroline M Tanner, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 16, 2019
Widespread Tau-Specific CD4 T Cell Reactivity in the General Population
Cecilia S Lindestam Arlehamn, John Pham, Roy N Alcalay, et al.
Neurodegenerative Disease Management
|
September 3, 2020
Application of the '5-2-1' screening criteria in advanced Parkinson's disease: interim analysis of DUOGLOBE
Jason Aldred, Marieta Anca-Herschkovitsch, Angelo Antonini, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2007
Molecular markers of early Parkinson's disease based on gene expression in blood
Clemens R Scherzer, Aron C Eklund, Lee J Morse, et al.
Page
of 19